Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.
By S. Waelter, A. Boeddrich, R. Lurz, E. Scherzinger, G. Lueder, Hans Lehrach, Erich E. Wanker. Molecular Biology of the Cell, 2001
657 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/23bcb47eb8dfc7c9fbef9effb0ba84e5e8df1f89
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Molecular Biology
Citations in the corpus
- Molecular mechanisms and potential therapeutical targets in Huntington's disease. (2010, background): “Huntingtin aggregates are labeled with antibodies to ubiquitin (48, 148, 619) and contain several proteasome subunits and chaperones (290, 494).”
- Stress granule assembly is mediated by prion-like aggregation of TIA-1. (2004, background): “Indeed, TIA-1 has been reported to be a component of huntingtin inclusions (Waelter et al., 2001).”
- Pathways of cellular proteostasis in aging and disease (2018, background): “, 2002), as exemplified by the fact that cellular aggregate deposits persist although they are typically associated with ubiquitin (Lowe et al., 1988; Bence et al., 2001; Waelter et al., 2001).”
- Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue (2010, result): “The relationship between SGs and neurodegenerative diseases has been suggested by previous experiments demonstrating that PrP, SMN and huntingtin colocalize with SG proteins in inclusions [26,27,28].”
- ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. (2002, background): “Because dysfunctions of UPS and the ER appear to be involved in the pathogenesis of many neurodegenerative diseases, ASK1 may be a potential therapeutic target for various neurodegenerative disorders represented by polyQ diseases.”